Source: Diabetes Care: 42 (Supplement 1)
Tag: Diabetes
Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes
OBJECTIVE Maturity-onset diabetes of the young (MODY) due to variants in HNF1A is the most common type of monogenic diabetes. Frequent misdiagnosis results in missed opportunity to use sulfonylureas as first-line treatment. A nongenetic biomarker could improve selection of subjects for genetic testing and increase diagnosis rates. We previously reported that plasma levels of antennary fucosylated N-glycans and high-sensitivity C-reactive protein (hs-CRP) are reduced in individuals with HNF1A-MODY. In this study, we examined the potential use of N-glycans and hs-CRP in discriminating individuals with damaging HNF1Aalleles from those without HNF1A variants in an unselected population of young adults with nonautoimmune diabetes.
Advanced training in diabetes care for healthcare professionals
The LifeScan Diabetes Institute provides advanced training in diabetes care for healthcare professionals
Source:Lifescan Diabetes Institute
Introduction: Standards of Medical Care in Diabetes—2019
Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Ongoing patient self-management education and support are critical to preventing acute complications and reducing the risk of long-term complications. Significant evidence exists that supports a range of interventions to improve diabetes outcomes.
Source: Introduction: Standards of Medical Care in Diabetes—2019
Vitamin D deficiency linked to greater risk of diabetes
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing diabetes.
Source: Vitamin D deficiency linked to greater risk of diabetes
AHA: Blood Test Could Offer Life-and-Death Clues for Black Diabetics
Testing blood for a biological marker called suPAR could help better assess the risk of death among black Americans with type 2 diabetes, according to a new study.
Source: AHA: Blood Test Could Offer Life-and-Death Clues for Black Diabetics
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice
Objective. Many patients with diabetes opt to fast for lab tests, especially for lipid profiles, thus missing breakfast. In parallel, recent studies and international guidelines have indicated that routine fasting for lipid panels may not be necessary. Missing breakfast while fasting for lab tests may invoke hypoglycemia, if patients are not properly instructed about adjusting diabetes medications on the night before or on the day of the lab test.
Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy – Endocrinology Advisor
Reports of immune checkpoint inhibitors causing immune-related adverse events such as insulin-dependent diabetes are on the rise, according to a case series published in Diabetes Care.
Source: Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy – Endocrinology Advisor
Metformin Shown to Decrease AMD Risk in Diabetes Patients
In a new study conducted in Taiwan, investigators found that use of metformin to treat diabetes also reduced the risk of AMD development over a 13-year period.
Source: Metformin Shown to Decrease AMD Risk in Diabetes Patients
Diabetes Management System Earns CE Mark
Diabeloop’s DBLG1, a hybrid closed-loop diabetes management system that serves as an artificial pancreas, earned a CE Mark. The device provides glucose measurements every five minutes and is able to connect to DexCom’s G6 Continuous Glucose Monitor, Kaleido’s patch insulin pump or a smartphone algorithm. It is the second CE Mark given to an artificial pancreas-like device, after Medtronics’ MiniMed 670G.